Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, Huberlant V, Schuerholz T, François B, Lascarrou JB, Beishuizen A, Oueslati H, Contou D, Hoiting O, Lacherade JC, Chousterman B, Pottecher J, Bauer M, Godet T, Karakas M, Helms J, Bergmann A, Zimmermann J, Richter K, Hartmann O, Pars M, Mebazaa A; AdrenOSS-2 study participants. Laterre PF, et al. Among authors: wittebole x. Intensive Care Med. 2021 Nov;47(11):1284-1294. doi: 10.1007/s00134-021-06537-5. Epub 2021 Oct 4. Intensive Care Med. 2021. PMID: 34605947 Free PMC article. Clinical Trial.
Ethanol therapy for methanol poisoning: duration and problems.
Hantson P, Wittebole X, Haufroid V. Hantson P, et al. Among authors: wittebole x. Eur J Emerg Med. 2002 Sep;9(3):278-9. doi: 10.1097/00063110-200209000-00015. Eur J Emerg Med. 2002. PMID: 12394629 No abstract available.
Anticoagulant therapy in acute lung injury.
Laterre PF, Wittebole X, Dhainaut JF. Laterre PF, et al. Among authors: wittebole x. Crit Care Med. 2003 Apr;31(4 Suppl):S329-36. doi: 10.1097/01.CCM.0000057912.71499.A5. Crit Care Med. 2003. PMID: 12682461 Review.
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.
Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, Lowry S, Dhainaut JF, Warren B, Dugernier T, Lopez A, Sanchez M, Demeyer I, Jauregui L, Lorente JA, McGee W, Reinhart K, Kljucar S, Souza S, Pribble J; Controlled Mortality Trial of Platelet-Activating Factor Acetylhydrolase in Severe Sepsis Investigators. Opal S, et al. Among authors: wittebole x. Crit Care Med. 2004 Feb;32(2):332-41. doi: 10.1097/01.CCM.0000108867.87890.6D. Crit Care Med. 2004. PMID: 14758145 Clinical Trial.
Electrocardiographic changes after head trauma.
Wittebole X, Hantson P, Laterre PF, Galvez R, Duprez T, Dejonghe D, Renkin J, Gerber BL, Brohet CR. Wittebole X, et al. J Electrocardiol. 2005 Jan;38(1):77-81. doi: 10.1016/j.jelectrocard.2004.09.004. J Electrocardiol. 2005. PMID: 15660352
Pharmacological inhibition of tissue factor.
Laterre PF, Wittebole X, Collienne C. Laterre PF, et al. Among authors: wittebole x. Semin Thromb Hemost. 2006 Feb;32(1):71-6. doi: 10.1055/s-2006-933342. Semin Thromb Hemost. 2006. PMID: 16479464 Review.
150 results